NYSE:PAH - Platform Specialty Products Stock Price, News, & Analysis

Platform Specialty Products trades on the New York Stock Exchange (NYSE) under the ticker symbol "PAH."

Platform Specialty Products Corp (NYSE:PAH) issued its earnings results on Thursday, August, 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. The specialty chemicals company had revenue of $1 billion for the quarter, compared to analyst estimates of $997.27 million. Platform Specialty Products had a positive return on equity of 8.48% and a negative net margin of 14.14%. The business's revenue was up 6.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.20 EPS. View Platform Specialty Products' Earnings History.

Platform Specialty Products issued an update on its FY 2019 earnings guidance on Monday, January, 28th. The company provided earnings per share guidance of $0.75-0.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.73. Platform Specialty Products also updated its FY 2018 guidance to EPS.

6 analysts have issued 1 year target prices for Platform Specialty Products' shares. Their forecasts range from $12.00 to $15.00. On average, they expect Platform Specialty Products' stock price to reach $13.25 in the next year. This suggests a possible upside of 30.8% from the stock's current price. View Analyst Price Targets for Platform Specialty Products.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Platform Specialty Products in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Platform Specialty Products.

Media headlines about PAH stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Platform Specialty Products earned a media sentiment score of 0.6 on InfoTrie's scale. They also assigned news stories about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.

Some companies that are related to Platform Specialty Products include Versum Materials (VSM), Element Solutions (ESI), Cabot (CBT), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience (PURE), HighCom Global Security (HCGS), GlyEco (GLYE), Artemis Therapeutics (ATMS) and Ener-Core (ENCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Platform Specialty Products investors own include Micron Technology (MU), Alibaba Group (BABA), Two Harbors Investment (TWO), Uniti Group (UNIT), Fitbit (FIT), Energy Transfer LP Unit (ET), Freeport-McMoRan (FCX), Intel (INTC), General Electric (GE) and Kratos Defense & Security Solutions (KTOS).

Platform Specialty Products' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (9.91%), BlackRock Inc. (5.74%), Dimensional Fund Advisors LP (5.50%), Gates Capital Management Inc. (2.33%), Vaughan Nelson Investment Management L.P. (1.41%) and Victory Capital Management Inc. (1.26%). Company insiders that own Platform Specialty Products stock include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Institutional Ownership Trends for Platform Specialty Products.

PAH stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Wedge Capital Management L L P NC, First Manhattan Co., First Trust Advisors LP, Raymond James & Associates, Victory Capital Management Inc., Van ECK Associates Corp and ETF Managers Group LLC. Company insiders that have sold Platform Specialty Products company stock in the last year include Martin E Franklin and Pershing Square Capital Manage. View Insider Buying and Selling for Platform Specialty Products.

PAH stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Consulta Ltd, Locust Wood Capital Advisers LLC, Vaughan Nelson Investment Management L.P., Gates Capital Management Inc., Royce & Associates LP, Hsbc Holdings PLC and BlackRock Inc.. Company insiders that have bought Platform Specialty Products stock in the last two years include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Insider Buying and Selling for Platform Specialty Products.

Shares of PAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PAH stock can currently be purchased for approximately $10.13.

Platform Specialty Products has a market capitalization of $2.92 billion and generates $3.78 billion in revenue each year. The specialty chemicals company earns $-296,200,000.00 in net income (profit) each year or $0.76 on an earnings per share basis.

The official website for Platform Specialty Products is http://www.platformspecialtyproducts.com.

Platform Specialty Products' mailing address is 1450 CENTREPARK BLVD SUITE 210, WEST PALM BEACH FL, 33401. The specialty chemicals company can be reached via phone at (561) 207-9600.